Kimberly Helms
Psychiatric/Mental Health · Clayton, NCNPI 1629726229
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,518 of the $9,039 with a category attached, or 61.0%. 24 manufacturers reported payments, led by Almatica Pharma LLC at 39.2% of the total. Reporting peaked in 2024 at $5,691 and has fallen 71.4% since, to $1,626 in 2025. Among psychiatric/mental health clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 354 payments — averaging $25.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Almatica Pharma LLC$4K
- Otsuka America Pharmaceutical, Inc.$806
- AbbVie$682
- Alkermes, Inc.$649
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$640
- Johnson & Johnson$451
- plus $2K from 18 others
What the payments were for
- Speaking & faculty fees$3,38337%
- Food & beverage$5,51861%
- Education$1392%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Almatica Pharma LLC | 18 | $3,540 |
| Otsuka America Pharmaceutical, Inc. | 48 | $806 |
| AbbVie | 56 | $682 |
| Alkermes, Inc. | 38 | $649 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 37 | $640 |
| Johnson & Johnson | 27 | $451 |
| Lundbeck LLC | 21 | $389 |
| Teva Pharmaceuticals USA, Inc. | 18 | $359 |
| Corium, LLC | 15 | $274 |
| Supernus Pharmaceuticals, Inc. | 21 | $227 |
| E.r. Squibb & Sons, L.L.C. | 8 | $165 |
| Axsome Therapeutics, Inc. | 6 | $129 |
| Neos Therapeutics, LP | 6 | $108 |
| Tris Pharma Inc | 6 | $100 |
| Neurocrine Biosciences, Inc. | 5 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $90 |
| Ironshore Pharmaceuticals Inc. | 4 | $71 |
| Merck | 3 | $50 |
| Collegium Pharmaceutical, Inc. | 3 | $49 |
| Noven Therapeutics, LLC | 2 | $42 |
| Bausch Health US, LLC | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Novo Nordisk | 2 | $33 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LOREEV XR$3,383
How this compares
$9,039 in reported general payments places this provider in the 95th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buspirone Hcl | 19 | $115 |
| Alprazolam | 11 | $100 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Clayton
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
- Deborah GranickRaleigh$28K
- Ronald PattersonFayetteville$25K
- Ajay PatelRaleigh$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.